Beyond Weight Loss: Modern Obesity Care Insights from ICOMES 2025
Dr. Donna from Medconsult Clinic Bangkok recently attended ICOMES 2025 in Seoul, one of Asia’s leading medical conferences on obesity and metabolic health. The event brought together international experts to discuss new research, treatment strategies, and innovations in holistic obesity care — moving beyond the traditional goal of simply losing weight.
Understanding Obesity as a Chronic Health Condition
Recent studies and expert presentations at ICOMES 2025 reinforced a vital message:
Obesity is a chronic, multi-system condition that impacts cardiovascular, metabolic, and liver health.
Modern obesity management now focuses on improving overall health, metabolism, and quality of life, not just reaching a lower number on the scale. This aligns with Medconsult Clinic’s integrated approach to weight management and preventive healthcare.
Key Study Highlight: The ESSENCE Phase 3 Trial
A major point of discussion was the ESSENCE Phase 3 trial, which evaluated semaglutide 2.4 mg in patients with Metabolic Dysfunction–Associated Steatohepatitis (MASH) — previously known as nonalcoholic steatohepatitis (NASH).
For patients with MASH stages F2–F3, treatment with semaglutide 2.4 mg demonstrated:
- Significant resolution of MASH and improvement in liver fibrosis
- Marked changes in secondary endpoints, including liver fibrosis–related non-invasive tests (NITs)
- Improved cardiometabolic health, including better blood sugar control, insulin sensitivity, and weight reduction
- Reported improvements in bodily comfort and pain scores
- A safe and consistent profile with no new safety concerns
These findings underscore semaglutide’s potential not only for weight loss but also for metabolic and liver health improvement — offering a comprehensive approach to obesity treatment.
Cardiovascular Benefits: More Than Just Weight
Another significant highlight presented at ICOMES 2025 revealed that semaglutide 2.4 mg can reduce the risk of major adverse cardiovascular events (MACE) by up to 20% in individuals with cardiovascular disease and obesity.
This result supports the broader understanding that effective obesity care directly contributes to heart health, metabolic stability, and long-term well-being.
The Key Takeaway: Health First, Weight Second
The message from ICOMES 2025 was clear:
“Obesity care is about health, not just weight. Weight loss is one outcome of effective obesity management.”
At Medconsult Clinic Bangkok, our doctors integrate medical weight management, nutritional counseling, and metabolic health monitoring to support patients in achieving sustainable health outcomes — safely and effectively.
Interested in personalized weight management or semaglutide treatment in Bangkok?
📍 Visit Medconsult Clinic Bangkok or contact us to book your consultation today.